We are live on ! Find out more
Fayez Sarofim & Co

Fayez Sarofim & Co Portfolio holdings

AUM $39.1B
1-Year Est. Return 15.14%
This Fund
S&P 500
This Quarter Est. Return
-11.46%
1 Year Est. Return
+15.14%
3 Year Est. Return
+57.14%
5 Year Est. Return
+86.44%
10 Year Est. Return
+281.86%
AUM
$16.6B
AUM Growth
-$2.56B
Cap. Flow
-$189M
Cap. Flow %
-1.14%
Top 10 Hldgs %
41.98%
Holding
251
New
10
Increased
48
Reduced
88
Closed
13

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$145M
2
SHW icon
Sherwin-Williams
SHW
+$33.7M
3
META icon
Meta Platforms (Facebook)
META
+$22.9M
4
AMZN icon
Amazon
AMZN
+$21.1M
5
MA icon
Mastercard
MA
+$17.9M

Top Sells

Rank Stock Value
1
PX
Praxair Inc
PX
+$160M
2
PM icon
Philip Morris
PM
+$52.2M
3
STT icon
State Street
STT
+$25.3M
4
AAPL icon
Apple
AAPL
+$19.5M
5
DIS icon
Walt Disney
DIS
+$17.3M

Sector Composition

Rank Sector Weight
1 Consumer Staples 25.44%
2 Financials 18.99%
3 Energy 14.69%
4 Technology 11.84%
5 Healthcare 10.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
USB icon
176
US Bancorp
USB
$98B
$500K ﹤0.01%
10,943
RACE icon
177
Ferrari
RACE
$69.9B
$497K ﹤0.01%
5,000
PB icon
178
Prosperity Bancshares
PB
$8.97B
$496K ﹤0.01%
7,965
YUM icon
179
Yum! Brands
YUM
$43.3B
$485K ﹤0.01%
5,280
CVS icon
180
CVS Health
CVS
$134B
$478K ﹤0.01%
+7,295
New +$545K
DHR icon
181
Danaher
DHR
$138B
$473K ﹤0.01%
5,170
+773
+18% +$70.2K
ABTX
182
DELISTED
Allegiance Bancshares
ABTX
$462K ﹤0.01%
14,286
HSBC icon
183
HSBC
HSBC
$367B
$461K ﹤0.01%
11,633
+575
+5% +$23K
QQQ icon
184
Invesco QQQ Trust
QQQ
$450B
$460K ﹤0.01%
+2,984
New +$499K
EW icon
185
Edwards Lifesciences
EW
$50B
$447K ﹤0.01%
8,760
-420
-5% -$21.3K
NWS icon
186
News Corp Class B
NWS
$17.2B
$435K ﹤0.01%
37,664
-50
-0.1% -$654
PYPL icon
187
PayPal
PYPL
$49.3B
$406K ﹤0.01%
4,828
ROK icon
188
Rockwell Automation
ROK
$52.4B
$403K ﹤0.01%
2,675
KMB icon
189
Kimberly-Clark
KMB
$36.6B
$394K ﹤0.01%
3,461
AOS icon
190
A.O. Smith
AOS
$8.24B
$384K ﹤0.01%
9,000
SYK icon
191
Stryker
SYK
$133B
$374K ﹤0.01%
2,385
-137
-5% -$22.9K
FBIN icon
192
Fortune Brands Innovations
FBIN
$5.88B
$373K ﹤0.01%
11,485
SEIC icon
193
SEI Investments
SEIC
$12.4B
$365K ﹤0.01%
7,900
REGN icon
194
Regeneron Pharmaceuticals
REGN
$77.4B
$364K ﹤0.01%
975
+150
+18% +$54.9K
IDXX icon
195
Idexx Laboratories
IDXX
$44.1B
$361K ﹤0.01%
1,942
+754
+63% +$155K
PBR.A icon
196
Petrobras Class A
PBR.A
$109B
$354K ﹤0.01%
30,500
AMCX icon
197
AMC Global Media
AMCX
$427M
$341K ﹤0.01%
6,220
MMP
198
DELISTED
Magellan Midstream Partners, L.P.
MMP
$340K ﹤0.01%
5,953
-1,644
-22% -$102K
WM icon
199
Waste Management
WM
$90.9B
$339K ﹤0.01%
3,812
CCK icon
200
Crown Holdings
CCK
$12.9B
$337K ﹤0.01%
8,100

Similar funds

Fayez Sarofim & Co's Q4 2018 Portfolio in Review

As of Q4 2018, Fayez Sarofim & Co held 251 positions worth $16.6B, down 13% from $19.1B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Fayez Sarofim & Co's Q4 2018 filing shows 10 new, 48 increased, 88 reduced and 13 closed positions. Its largest new stake was Linde: 915,945 shares worth $143M. The largest sale was Praxair Inc, an estimated $160M.

By sector, the portfolio is most concentrated in Consumer Staples at 25% of assets, up from 25% a quarter earlier, followed by Financials and Energy.

  • Fayez Sarofim & Co's largest Q4 2018 buy was Linde: 915,945 shares worth $143M.
  • Fayez Sarofim & Co added most to Sherwin-Williams in Q4 2018, an estimated $33.7M increase.
  • Fayez Sarofim & Co's biggest Q4 2018 reduction was Philip Morris, cutting an estimated $52.2M.
  • Fayez Sarofim & Co fully exited Praxair Inc in Q4 2018, selling an estimated $160M.
  • Fayez Sarofim & Co's ten largest holdings make up 42% of its $16.6B portfolio in Q4 2018.
  • Fayez Sarofim & Co opened 10 new positions and closed 13 in Q4 2018.
  • Fayez Sarofim & Co's portfolio value fell 13% quarter-over-quarter to $16.6B.

Based on Fayez Sarofim & Co's 13F filing for Q4 2018, filed 13 Feb 2019.